The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness …
Industry Peers
Household & Personal Products| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This week | ||
 Is Ecolab Stock Worth Buying as Growth Rises but Debt Risk Builds? ECL's accelerating High-Tech, Digital and Life Sciences growth supports its outlook, but rising debt and financing costs keep the buy case cautious. | ||
 Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX) Church & Dwight Co., Inc. (NYSE:CHD) and The Clorox Company (NYSE:CLX) look quite different when it comes to dividends. CHD offers a much lower yield, but its dividend is growing faster. Clorox gives investors far more income today, though the company has been much more conservative with recent increases. Church & Dwight Co., Inc. (NYSE:CHD) […] | IInsider Monkey | |
Older | ||
 Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink? As Clorox has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects. | ||
 Is ENR a Buy as Low Valuation Clashes With Weak Growth and Margins? ENR trades at a steep discount, but weak earnings, margin pressure and soft battery demand challenge the case for a rebound. | ||
 The Top 5 Analyst Questions From Clorox’s Q2 Earnings Call Clorox’s second quarter generated a positive response from investors, as revenue surpassed analyst expectations despite a 2% year-over-year decline. Management attributed the quarter’s performance to targeted improvements in product superiority, focused brand investments, and effective promotional execution in key categories. CEO Linda Rendle noted that, “the majority of our businesses are performing at or above expectations,” while acknowledging operational challenges in segments like Litter an | SStockStory | |
 Clorox (CLX) Q4 2026 Earnings Call Transcript GOJO acquisition boosts health segment as organic sales decline amid inflation headwinds. | ||
 Clorox says ERP transition will provide supply chain gains this year The household cleaning and consumer products maker expects improvements through better planning, lower inventory levels and more automation. | ||
 Clorox expects $200M inflation hit, supply chain costs a factor Increasing energy, commodity and supplier costs are significant contributors, along with higher trucking, ocean freight and logistics-related expenses. | ||
 NWL vs. CLX: Which Stock Is the Better Value Option? NWL vs. CLX: Which Stock Is the Better Value Option? | ||
 Clorox (CLX) Sees 14% Sales Growth Even As Fiscal 2027 Headwinds Persist Clorox (NYSE:CLX) outlined its fiscal 2027 outlook, highlighting ongoing operational headwinds and inflation risks. The company is forecasting net sales growth of 13% to 14% for fiscal 2027, largely tied to the acquisition of GOJO Industries and the Purell brand. Clorox reported fiscal 2026 results that were in line with prior expectations and used the update to detail how the GOJO and Purell integration could affect future revenue and earnings. Clorox enters this update with the stock... | ||